Anti-Cancer Agents in Medicinal Chemistry

(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

This journal supports open access

Editor-in-Chief:

Michelle Prudhomme
Institut de Chimie de Clermont-Ferrand
ICCF-CNRS UMR 6296
Université Clermont Auvergne
Clermont-Ferrand
France

Back

Become EABM
Become Reviewer

Editorial [Hot Topic: Tyrosine Kinase Inhibitors in Cancer Therapy (Guest Editor: S. Eckhardt)] promotion: free to download

Volume:8   Issue: 5
Pp: 461-461
S. Eckhardt
DOI: 10.2174/187152008784533053

Antiangiogenic Drugs and Tyrosine Kinases

Volume:8   Issue: 5
Pp: 462-469
Jozsef Timar and Balazs Dome
DOI: 10.2174/187152008784533035

Novel Molecular-Targeted Therapeutics for the Treatment of Cancer

Volume:8   Issue: 5
Pp: 470-480
Hiroshi Yasui and Kohzoh Imai
DOI: 10.2174/187152008784533099

HER-2 Positive Breast Cancer: What Else Beyond Trastuzumab-Based Therapy?

Volume:8   Issue: 5
Pp: 488-496
Christian Widakowich, Phuong Dinh, Evandro de Azambuja, Ahmad Awada and Martine Piccart-Gebhart
DOI: 10.2174/187152008784533062

New Trends in Molecular Imaging of Tumor Angiogenesis

Volume:8   Issue: 5
Pp: 497-522
Thomas Berthelot, Marie-Claire Lasne and Gerard Deleris
DOI: 10.2174/187152008784533026

Monoclonal Antibodies in Clinical Oncology

Volume:8   Issue: 5
Pp: 523-532
S. Dalle, C. Thieblemont, L. Thomas and C. Dumontet
DOI: 10.2174/187152008784533071

p53 Targeting Can Enhance Cancer Therapy via Radiation, Heat and Anti-Cancer Agents

Volume:8   Issue: 5
Pp: 564-570
Takeo Ohnishi, Akihisa Takahashi, Eiichiro Mori and Ken Ohnishi
DOI: 10.2174/187152008784533017

Hyperthermia Associated Osteonecrosis in Young Patients with Pelvic Malignancies

Volume:8   Issue: 5
Pp: 571-575
Marcus Jager, Stefan Balzer, Rudiger Wessalowski, J. Schaper, Ulrich Gobel, Xinning Li and Rudiger Krauspe
DOI: 10.2174/187152008784533044